Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Nov 15, 2022; 14(11): 2208-2223
Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2208
Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2208
Table 1 Patients’ main characteristics
Αdenocarcinoma, n = 56 | Colon polyps, n = 33 | Controls, n = 81 | |
Age in yr, n (%) | |||
50-59 | 1 (1.8) | 8 (24.2) | 9 (11.1) |
60-69 | 20 (35.7) | 12 (36.4) | 44 (54.3) |
70-79 | 28 (50.0) | 11 (33.3) | 16 (19.8) |
80-94 | 7 (12.5) | 2 (6.1) | 12 (14.8) |
Sex | |||
Men | 35 (62.5) | 21 (63.6) | 44 (54.3) |
Women | 21 (37.5) | 12 (36.4) | 37 (45.7) |
Smoking | |||
Yes | 50 (89.3) | 17 (51.5) | 68 (84.0) |
No | 6 (10.7) | 16 (48.5) | 13 (16.0) |
Number of cigarettes/d | |||
< 20 | 4 ± 8.0 | 3 ± 17.6 | 0 ± 0.0 |
20 | 10 ± 20.0 | 6 ± 35.3 | 20 ± 29.4 |
> 20 | 36 ± 72.0 | 8 ± 47.1 | 48 ± 70.6 |
Smoking duration in yr (mean ± SD) | 37.7 ± 10.0 | 33.5 ± 9.1 | 40.3 ± 6.2 |
Table 2 Distribution (median 25-75 percentile) of antioxidants and oxidants compounds in the plasma by group
Αdenocarcinoma, n = 56 | Colon polyps, n = 33 | Controls, n = 81 | |
Αntioxidants | |||
Αntioxidant capacity in μmol/L | 185.0 (177.0-190.0) | 190.0 (182.0-196.2) | 305.0 (298.0-324.0) |
Vitamin Α in μg/L | 391.5 (288.3-493.8) | 572.0 (480.0-609.0) | 380.0 (350.0-416.0) |
Vitamin C in μg/L | 4.7 (3.9-6.5) | 6.0 (4.7-10.0) | 6.0 (4.5-9.0) |
Vitamin E in mg/L | 3.5 (2.4-3.9) | 3.8 (3.5-4.2) | 3.7 (3.2-4.0) |
Vitamin D in ng/mL | 9.0 (6.7-13.0) | 9.0 (6.8-20.5) | 24.0 (20.0-26.0) |
Se in μg/L | 62.0 (45.5-78.8) | 78.0 (72.0-80.0) | 76.0 (69.5-80.0) |
Zn in μg/L | 626.5 (594.5-782.5) | 800.0 (711.0-840.0) | 809.0 (780.5-842.5) |
B12 in pg/L | 211.0 (159.3-297.0) | 250.0 (220.0-355.0) | 289.0 (200.0-340.0) |
Folic acid in ng/L | 4.3 (3.3-4.6) | 4.2 (3.9-4.6) | 4.0 (3.8-4.4) |
Οxidants | |||
Οxidant activity in μmol/L | 368.8 (330.8-409.0) | 378.0 (348.5-409.1) | 172.0.0 (167.5-178.5) |
Μalondialdehyde in μmol/L) | 1.9 (1.6-2.4) | 1.2 (0.9-2.0) | 1.8 (1.7-1.9) |
Fe2+ in μg/dL) | 64.0 (49.3-92.3) | 110.0 (90.0-127.0) | 68.0 (51.0-95.0) |
Table 3 Percent change (and 95%CIs respectively) in the levels of serum antioxidant and oxidant substances compared to the control group
Colon polyps | Colon adenocarcinoma | |
% Change (95%CI) | % Change (95%CI) | |
Antioxidants | ||
Antioxidant capacity | -40.1 (-41.6 to -38.5) | -40.7 (-41.8 to -39.5) |
Vitamin Α | 32.2 (20.8 to 44.7) | 0.1 (-6.9 to 7.6) |
Vitamin C | -3.1 (-15.8 to 11.6) | -12.7 (-21.9 to -2.4) |
Vitamin E | 4.2 (-5.0 to 14.2) | -12.3 (-18.4 to -5.7) |
Vitamin D | -46.0 (-54.9 to -35.4) | -56.8 (-62.6 to -50.2) |
Se | 1.7 (-6.3 to 10.4) | -19.4 (-24.5 to -14.0) |
Zn | -6.7 (-12.9 to 0.0) | -20.2 (-24.5 to -15.7) |
B12 | 6.0 (-11.7 to 27.2) | -15.0 (-26.5 to -1.8) |
Folic acid | 2.1 (-6.9 to 12.0) | -8.2 (-14.7 to -1.3) |
Oxidants | ||
Oxidant activity | 120.1 (111.7 to 128.9) | 113.4 (106.8 to 120.2) |
Malondialdehyde | -31.6 (-39.8 to -22.3) | 10.1 (-0.6 to 21.9) |
Fe2+ | 43.5 (22.2 to 68.5) | -8.9 (-19.8 to 3.5) |
Table 4 Results from multiple logistic regression models (odds ratios and 95%CIs) for the risk of colon adenocarcinoma in comparison to the control group1
Odds ratio | 95%CI | P value | |
Antioxidants | |||
Vitamin Α, per 99.6 μg/L | 1.20 | 0.77-1.88 | 0.430 |
Vitamin C, per 2.8 μg/L | 0.71 | 0.44-1.15 | 0.168 |
Vitamin E, per 0.7 mg/L | 0.57 | 0.39-0.84 | 0.004 |
Vitamin D, per 8.2 ng/mL | 0.04 | 0.02-0.12 | < 0.001 |
Se, per 13.6 μg/L | 0.35 | 0.22-0.55 | < 0.001 |
Zn, per 128.5 μg/L | 0.16 | 0.09-0.31 | < 0.001 |
B12, per 157.1 pg/L | 0.80 | 0.51-1.26 | 0.337 |
Folic acid, per 38.1 ng/L | 0.77 | 0.54-1.11 | 0.170 |
Oxidants | |||
Malondialdehyde, per 0.5 μmol/L | 2.09 | 1.27-3.45 | 0.004 |
Fe2+, per 33.9 μg/dL | 0.73 | 0.47-1.13 | 0.154 |
Table 5 Multiple logistic regression results (odds ratios and 95%CIs) for the risk of colon polyp development in comparison to the control group1
Odds ratio | 95%CI | P value | |
Antioxidants | |||
Vitamin Α, per 99.6 μg/L | 8.84 | 3.76-20.74 | < 0.001 |
Vitamin C, per 2.8 μg/L | 0.99 | 0.58-1.70 | 0.982 |
Vitamin E, per 0.7 mg/L | 1.51 | 0.87-2.63 | 0.141 |
Vitamin D, per 8.2 ng/mL | 0.27 | 0.15-0.48 | < 0.001 |
Se, per 13.6 μg/L | 1.68 | 0.82-3.42 | 0.157 |
Zn, per 128.5 μg/L | 0.39 | 0.16-0.94 | 0.036 |
B12, per 157.1 pg/L | 1.51 | 0.92-2.46 | 0.103 |
Folic acid, per 38.1 ng/L | 1.42 | 0.74-2.72 | 0.299 |
Οxidants | |||
Malondialdehyde, per 0.5 μmol/L | 0.35 | 0.20-0.60 | < 0.001 |
Fe2+, per 33.9 μg/dL | 2.58 | 1.53-4.33 | < 0.001 |
- Citation: Tsounis D, Villiotou V, Melpidou A, Pantsiou C, Argyrou A, Giannopoulou C, Grigoratou A, Rontogianni D, Mantzaris GJ, Papatheodoridis G. Oxidative imbalance increases the risk for colonic polyp and colorectal cancer development. World J Gastrointest Oncol 2022; 14(11): 2208-2223
- URL: https://www.wjgnet.com/1948-5204/full/v14/i11/2208.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i11.2208